The Latest Cardiac and Vascular News
KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., the AI-Powered Cardiac Blood Test Company, today announces the presentation of patient data demonstrating that its Artificial Intelligence (AI)-driven HART® CVE blood test is highly accurate for risk assessment in patients with total blockage of a heart artery, also known as coronary Chronic Total Occlusion (CTO). Researchers from Massachusetts General Hospital (MGH) tested 241 patients with chronic total occlusion of at least one coronary (hea
CoSo Health to exclusively distribute Medinol’s most advanced coronary DES in the U.S. DENVER and TEL AVIV, Israel, Oct. 24, 2023 /PRNewswire/ — Medinol today announced United States Food and Drug Administration (FDA) approval for the EluNIR-PERL™ drug-eluting stent (DES) for the…
Research affirms Implicity’s algorithm* is highly effective at identifying patterns and classifying AF episodes into medically relevant events that require clinical action CAMBRIDGE, Mass., Oct. 24, 2023 /PRNewswire/ — Implicity, a leader in remote patient monitoring (RPM) and cardiac…
MIAMI LAKES, Fla., Oct. 24, 2023 /PRNewswire/ — Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, has announced completion of patient enrollment in SUCCESS PTA, its large post-market study with the SELUTION SLR™…
NEUCHATEL, Switzerland, Oct. 24, 2023 /PRNewswire/ — Aktiia SA, the world leader in cuffless blood pressure technology, is proud to announce its collaboration with the Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors (GAPP) study investigators,…
SUNNYVALE, Calif., Oct. 23, 2023 /PRNewswire/ — EBR Systems, Inc. (ASX:EBR), the developer of the world’s only wireless cardiac pacing device for heart failure, is pleased to announce it has been named as a nominee for the 2023 Medical Technology Association of Australia (MTAA) Kerrin Rennie award. This nomination by the MTAA recognizes the potential of EBR Systems’ […]
BURLINGAME, Calif., Oct. 23, 2023 /PRNewswire/ — Genesis MedTech, a leading medical device company, today announced initiation of enrolment in its North American Early Feasibility Study using its dedicated TAVR system, J-Valve™ Transfemoral (TF) System. The procedure was successfully performed by Dr. Dean Kereiakes, MD, Dr. Santiago Garcia, MD, and the team at The Lindner […]
SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ — Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray’s diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management. While CVDs are the leading cause of death […]
LIVERMORE, Calif., Oct. 23, 2023 /PRNewswire/ — Advanced Bifurcation Systems Inc. (ABS), a pioneer in comprehensive solutions for bifurcation lesions in coronary angioplasty, today announced that it has received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its novel coronary artery bifurcation stenting technology. This prestigious designation […]
JUPITER, FL, Oct. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Marizyme, Inc. (“Marizyme” or the “Company”) (OTCQB: MRZM), today provided the following business update to the stockholders and the investing public from the Company’s Chief Executive Officer, David Barthel: “I am very pleased to bring you an update on […]
